44 Wealth Management’s Novo Nordisk NVO Stock Holding History

44 Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,824	Closed	-$212K	–	208
2025 Q3	$212K	Sell	3,824 -742	-16%	-$43.4K	0.07%	195
2025 Q2	$315K	Buy	+4,566	New	+$311K	0.11%	171
2025 Q1	–	Sell	-2,759	Closed	-$237K	–	199
2024 Q4	$237K	Sell	2,759 -185	-6%	-$20K	0.09%	180
2024 Q3	$341K	Buy	+2,944	New	+$393K	0.12%	161
2023 Q2	$559K	Buy	6,908 +140	+2%	+$11.4K	0.19%	101
2023 Q1	$539K	Sell	6,768 -10	-0.1%	-$709	0.18%	101
2022 Q4	$459K	Buy	6,778 +380	+6%	+$22.3K	0.16%	109
2022 Q3	$319K	Buy	6,398 +600	+10%	+$32.1K	0.13%	130
2022 Q2	$323K	Buy	+5,798	New	+$322K	0.12%	130

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

44 Wealth Management's NVO Position: Q4 2025 in Review

44 Wealth Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 3,824 shares — an estimated $212K sold.

44 Wealth Management first reported a position in NVO in Q2 2022 and held it in 9 quarters. The position peaked at $559K in Q2 2023. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

44 Wealth Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
44 Wealth Management sold 3,824 Novo Nordisk shares in Q4 2025, an estimated $212K.
44 Wealth Management first reported a position in Novo Nordisk in Q2 2022 and held it in 9 quarters.
44 Wealth Management's Novo Nordisk position peaked at $559K in Q2 2023.
1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on 44 Wealth Management's 13F filing for Q4 2025, filed 9 Feb 2026.